These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38869133)

  • 1. [Prevention of contrast-induced nephropathy].
    Cousin F; Moïse M; Ilbert C; Meunier P; Jouret F
    Rev Med Liege; 2024 Jun; 79(5-6):418-423. PubMed ID: 38869133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Iodinated contrast agent-induced nephropathy].
    Erley C
    Radiologe; 2007 Sep; 47(9):761-7. PubMed ID: 17823784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors.
    Andreucci M; Faga T; Pisani A; Sabbatini M; Russo D; Michael A
    ScientificWorldJournal; 2014; 2014():823169. PubMed ID: 25525625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimetazidine in the prevention of contrast-induced nephropathy in chronic kidney disease.
    Ibrahim TA; El-Mawardy RH; El-Serafy AS; El-Fekky EM
    Cardiovasc Revasc Med; 2017; 18(5):315-319. PubMed ID: 28532702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiographic contrast nephropathy].
    Andreucci M
    G Ital Nefrol; 2014; 31(5):. PubMed ID: 25315721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
    Feldkamp T; Kribben A
    Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
    Marenzi G; Ferrari C; Marana I; Assanelli E; De Metrio M; Teruzzi G; Veglia F; Fabbiocchi F; Montorsi P; Bartorelli AL
    JACC Cardiovasc Interv; 2012 Jan; 5(1):90-7. PubMed ID: 22230154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-Induced Nephropathy: From Pathophysiology to Preventive Strategies.
    Azzalini L; Spagnoli V; Ly HQ
    Can J Cardiol; 2016 Feb; 32(2):247-55. PubMed ID: 26277092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-induced nephropathy: Pathophysiology, risk factors, and prevention.
    Hossain MA; Costanzo E; Cosentino J; Patel C; Qaisar H; Singh V; Khan T; Cheng JS; Asif A; Vachharajani TJ
    Saudi J Kidney Dis Transpl; 2018; 29(1):1-9. PubMed ID: 29456202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of iodinated contrast-induced nephropathy.
    Li JH; He NS
    Chin Med J (Engl); 2011 Dec; 124(23):4079-82. PubMed ID: 22340345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches.
    Kusirisin P; Chattipakorn SC; Chattipakorn N
    J Transl Med; 2020 Oct; 18(1):400. PubMed ID: 33081797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remote Ischemic Preconditioning To Reduce Contrast-Induced Nephropathy: A Randomized Controlled Trial.
    Menting TP; Sterenborg TB; de Waal Y; Donders R; Wever KE; Lemson MS; van der Vliet JA; Wetzels JF; SchultzeKool LJ; Warlé MC
    Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):527-32. PubMed ID: 26015372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodinated contrast media-induced nephropathy: pathophysiology, clinical aspects and prevention.
    Idée JM; Beaufils H; Bonnemain B
    Fundam Clin Pharmacol; 1994; 8(3):193-206. PubMed ID: 7927115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures.
    Schweiger MJ; Chambers CE; Davidson CJ; Blankenship J; Bhalla NP; Block PC; Dervan JP; Gasperetti C; Gerber L; Kleiman NS; Krone RJ; Phillips WJ; Siegel RM; Uretsky BF; Laskey WK
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):135-40. PubMed ID: 17139671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-induced nephropathy: pharmacological prophylaxis.
    Briguori C; Marenzi G
    Kidney Int Suppl; 2006 Apr; (100):S30-8. PubMed ID: 16612399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-induced nephropathy: epidemiology and prevention.
    Bagshaw SM; Culleton BF
    Minerva Cardioangiol; 2006 Feb; 54(1):109-29. PubMed ID: 16467746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why is diabetes mellitus a risk factor for contrast-induced nephropathy?
    Heyman SN; Rosenberger C; Rosen S; Khamaisi M
    Biomed Res Int; 2013; 2013():123589. PubMed ID: 24350240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevention of contrast-induced nephropathy.
    Au TH; Bruckner A; Mohiuddin SM; Hilleman DE
    Ann Pharmacother; 2014 Oct; 48(10):1332-42. PubMed ID: 24994723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
    Calabrò P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; Calabrò R
    Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012.
    Owen RJ; Hiremath S; Myers A; Fraser-Hill M; Barrett BJ
    Can Assoc Radiol J; 2014 May; 65(2):96-105. PubMed ID: 24559602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.